1990).
3. Okada, Y., In: GABAergic Mechanisms in the
Mammalian Periphery, Erdo, S. and Bowery, N.,
(Eds.), Raven Press, New York, p. 223 (1986).
4. Kanner, B.I., J. Exp. Biol., 196, 237 (1994).
5
1990).
3. Okada, Y., In: GABAergic Mechanisms in the
Mammalian Periphery, Erdo, S. and Bowery, N.,
(Eds.), Raven Press, New York, p. 223 (1986).
4. Kanner, B.I., J. Exp. Biol., 196, 237 (1994).
5
1990).
3. Okada, Y., In: GABAergic Mechanisms in the
Mammalian Periphery, Erdo, S. and Bowery, N.,
(Eds.), Raven Press, New York, p. 223 (1986).
4. Kanner, B.I., J. Exp. Biol., 196, 237 (1994).
Carpenter, F.H., Treatment of trypsin with TPCK.
Methods Enzymol., 11, 237 (1967).
13. Methods of Molecular Biology, Vol. 3, Smith, B.J.,
Humana Press, (New Jersey, 1988), pp. 57-69.
14. Porter
:
1989), p. 240.
10. Carpenter, F.H., Treatment of trypsin with TPCK.
Methods Enzymol., 11, 237 (1967).
11. Sipos, T., and Merkel, J.R., An effect of calcium
ions on the activity, heat stability
application of ion- selective
optode membranes as well as recent developments in this field. With 237 references. published by Fluka Chemie GmbH,
Buchs, Switzerland (1993); K. Seiler, Ionenselektive Optodenmembranen
NY:
1989), p. 240.
9. Carpenter, F. H., Treatment of trypsin with TPCK.
Methods Enzymol., 11, 237 (1967).
10. Sipos, T., and Merkel, J. R., An effect of calcium
ions on the activity, heat
NY: 1989),
p. 240.
10. Carpenter, F.H., Treatment of trypsin with TPCK.
Methods Enzymol., 11, 237 (1967).
11. Sipos, T., and Merkel, J.R., An effect of calcium
ions on the activity, heat stability
of protein. Anal. Biochem., 239, 223-237 (1996).
2. Singer, V. L., et al., Highly Sensitive SYPRO
Fluorescent Protein Gel Stains. J. NIH Res., 7, 82
(1995).
3. Steinberg, T. H., et al., Applications
Carpenter, F. H., Treatment of trypsin with TPCK.
Methods Enzymol., 11, 237 (1967).
13. Methods of Molecular Biology, Vol. 3, Smith, B. J.,
Humana Press, (New Jersey, 1988), pp. 57-69.
14. Porter
001181985.1 ,NP_001181986.1,NP_004074.2 y n/d y
64 Seladin S4697 1718 DHCR24 M NP_055577.1 y n/d n/d
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226
001181985.1 ,NP_001181986.1,NP_004074.2 y n/d y
64 Seladin S4697 1718 DHCR24 M NP_055577.1 y n/d n/d
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226
001181985.1 ,NP_001181986.1,NP_004074.2 y n/d y
64 Seladin S4697 1718 DHCR24 M NP_055577.1 y n/d n/d
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226
DR4 D3813 P y n/d n/d
234 DR5 D3938 P y n/d n/d
235 DR6 D1564 P y n/d n/d
236 DRAK1 D1314 P y y y
237 Dystrophin D8168 M y y y
238 Dystrophin D8043 M y y y
239 E2F1 E9026 P y